The store will not work correctly when cookies are disabled.
2-phenyl-4-(1,2,2,2-tetrafluoroethyl)-3H-benzo[b][1,4]diazepine
ID: ALA5176722
PubChem CID: 168272138
Max Phase: Preclinical
Molecular Formula: C17H12F4N2
Molecular Weight: 320.29
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: FC(C1=Nc2ccccc2N=C(c2ccccc2)C1)C(F)(F)F
Standard InChI: InChI=1S/C17H12F4N2/c18-16(17(19,20)21)15-10-14(11-6-2-1-3-7-11)22-12-8-4-5-9-13(12)23-15/h1-9,16H,10H2
Standard InChI Key: RIEZALSCXNZTRS-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
-2.4242 0.2969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7096 0.7092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9977 0.2973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9977 -0.5278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7078 -0.9396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4242 -0.5315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3553 0.8154 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4486 0.6390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8159 -0.1065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4623 -0.8529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3435 -1.0431 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0321 1.2225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8185 2.0196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8292 1.0088 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.0214 2.2332 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.4020 2.6031 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.6049 2.8166 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.0458 -1.4363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8430 -1.2230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4242 -1.8053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2105 -2.6025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4178 -2.8166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8313 -2.2369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
3 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
11 10 2 0
4 11 1 0
8 12 1 0
12 13 1 0
12 14 1 0
13 15 1 0
13 16 1 0
13 17 1 0
10 18 1 0
19 18 2 0
20 19 1 0
21 20 2 0
22 21 1 0
23 22 2 0
18 23 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 320.29 | Molecular Weight (Monoisotopic): 320.0937 | AlogP: 5.18 | #Rotatable Bonds: 2 |
Polar Surface Area: 24.72 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 1.85 | CX LogP: 5.34 | CX LogD: 5.34 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.68 | Np Likeness Score: -0.56 |
References
1. Morales-Tenorio M, Ginex T, Cuesta-Geijo MÁ, Campillo NE, Muñoz-Fontela C, Alonso C, Delgado R, Gil C.. (2021) Potential pharmacological strategies targeting the Niemann-Pick C1 receptor and Ebola virus glycoprotein interaction., 223 [PMID:34175537] [10.1016/j.ejmech.2021.113654] |